Rademeyer et al., 2016 - Google Patents
Features of recently transmitted HIV-1 clade C viruses that impact antibody recognition: implications for active and passive immunizationRademeyer et al., 2016
View HTML- Document ID
- 9309009289307790653
- Author
- Rademeyer C
- Korber B
- Seaman M
- Giorgi E
- Thebus R
- Robles A
- Sheward D
- Wagh K
- Garrity J
- Carey B
- Gao H
- Greene K
- Tang H
- Bandawe G
- Marais J
- Diphoko T
- Hraber P
- Tumba N
- Moore P
- Gray G
- Kublin J
- McElrath M
- Vermeulen M
- Middelkoop K
- Bekker L
- Hoelscher M
- Maboko L
- Makhema J
- Robb M
- Abdool Karim S
- Abdool Karim Q
- Kim J
- Hahn B
- Gao F
- Swanstrom R
- Morris L
- Montefiori D
- Williamson C
- Publication year
- Publication venue
- PLoS pathogens
External Links
Snippet
The development of biomedical interventions to reduce acquisition of HIV-1 infection remains a global priority, however their potential effectiveness is challenged by very high HIV-1 envelope diversity. Two large prophylactic trials in high incidence, clade C epidemic …
- 241000700605 Viruses 0 title abstract description 236
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rademeyer et al. | Features of recently transmitted HIV-1 clade C viruses that impact antibody recognition: implications for active and passive immunization | |
| Gnanakaran et al. | Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections | |
| deCamp et al. | Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies | |
| Wagh et al. | Completeness of HIV-1 envelope glycan shield at transmission determines neutralization breadth | |
| Gnanakaran et al. | Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies | |
| Roederer et al. | Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV | |
| Souquière et al. | Wild Mandrillus sphinx are carriers of two types of lentivirus | |
| Dingens et al. | Comprehensive mapping of HIV-1 escape from a broadly neutralizing antibody | |
| Corbet et al. | env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area | |
| Novitsky et al. | Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? | |
| Lim et al. | The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx | |
| Wood et al. | HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC | |
| Lynch et al. | The development of CD4 binding site antibodies during HIV-1 infection | |
| Hraber et al. | Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies | |
| Curlin et al. | HIV-1 envelope subregion length variation during disease progression | |
| Smith et al. | Diversification in the HIV-1 envelope hyper-variable domains V2, V4, and V5 and higher probability of transmitted/founder envelope glycosylation favor the development of heterologous neutralization breadth | |
| Stefic et al. | Sensitivity to broadly neutralizing antibodies of recently transmitted HIV-1 clade CRF02_AG viruses with a focus on evolution over time | |
| Casado et al. | Identification of a cluster of HIV-1 controllers infected with low replicating viruses | |
| Kijak et al. | Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial | |
| Gonzalez et al. | Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission | |
| Schorcht et al. | Neutralizing antibody responses induced by HIV-1 envelope glycoprotein SOSIP trimers derived from elite neutralizers | |
| DeLeon et al. | Accurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model | |
| Chaillon et al. | Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection | |
| Ince et al. | Evolution of the HIV-1 env gene in the Rag2−/− γC−/− humanized mouse model | |
| Kinloch et al. | Genotypic and mechanistic characterization of subtype-specific HIV adaptation to host cellular immunity |